Determinants of mortality in elderly patients with heart failure: The role of angiotensin-converting enzyme inhibitors

Archives of Internal Medicine

Volumn 158, Issue 18, 1998, Pages 2024-2028

  Havranek, Edward P ^a,b   Abrams, Fredrich ^a   Stevens, Elizabeth ^a   Parker, Kelly ^a  

^a Colorado Foundation for Medical Care ^*  (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG INDICATION; ELDERLY CARE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICARE; MORTALITY; MULTIVARIATE ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COLORADO; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PATIENT SELECTION; RISK; RISK FACTORS;

EID: 0032511759     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.18.2024     Document Type: Article

References (22)

1. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301-306.
2. Parmley WW. Cost-effective management of heart failure. Clin Cardiol. 1996;19: 240-242.
3. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant. 1994;13:S107-S112.
4. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization among Medicare beneficiaries. Arch Intern Med. 1997;157:99-104.
5. Konstam M, Dracup K, Bottorff MB, et al. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. In: Clinical Practice Guideline No. 11. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service, US Dept of Health and Human Services; 1994. AHCPR publication 94-0612.
6. ACC/AHA Task Force on Practice Guidelines. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376-1398.
7. Hadorn DC, Baker DW, Kamberg CJ, Brook RH. Phase II of the AHCPR-sponsored heart failure guideline: translating practice recommendations into review criteria. J Qual Improve. 1996;22:265-276.
8. Rajfer SI. Perspective of the pharmaceutical industry on the development of new drugs for heart failure. J Am Coll Cardiol. 1993;22(suppl A):198A-200A.
9. Philbin EF, Andreou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 1996;77:832-838.
10. McDermott MM, Feinglass J, Lefevre F, et al. Outcomes for 1617 patients hospitalized with congestive heart failure between 1986 and 1994: trends in patient characteristics, drug prescribing practices, hospital readmissions, and survival. J Gen Intern Med. 1996;11(suppl 1):80.
11. Edep ME, Shah NB, Tateo I, Massie BM. Differences between primary care physicians and cardiologists, family practitioners in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997;30:518-526.
12. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingnam Study. N Engl J Med. 1971;285:1441-1446.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
14. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
15. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989:135-149.
16. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991; 325:293-302.
17. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450-1456.
18. Stevenson WG, Stevenson LW, Middlekauf HR, et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol. 1995;26:1417-1423.
19. Wennberg JE, Cooper MM, eds. The Dartmouth Atlas of Health Care. Chicago, III: American Hospital Publishing Inc; 1996:113-144.
20. Havranek EP, Graham GW, Pan Z, Lowes B. Process and outcome of outpatient management of heart failure: a comparison of cardiologists and primary care providers. Am J Managed Care. 1996;2:783-789.
21. Philbin EF, Weil HF, Erb T. Outcomes in heart failure based on specialty care. Circulation. 1996;94:I-50.
22. Harjari KJ, Boulos LM, Smart FW, et al. Clinical outcomes following admission for heart failure: how does the generalist compare with the specialist [abstract]? Circulation. 1996;94:I-50.